Dr. Tatiana A. Egorova-Zachernyuk is the founder (2000) and CEO of an independent research oriented technology platform company PLI Technologies, Leiden, The Netherlands. PLI is based in a part of Europe well-known for its expertise in life sciences. PLI’s major ambitions are to contribute to the challenges of preventive, predictive and personalized medicine (PPPM), to develop novel technologies for the pharmaceutical and the food & nutrition market.